The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Ben‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604713 · Cited by 462
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Zavascki, A. P., Carvalhaes, C. G., Picão, R. C., & Gales, A. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.108 · Cited by 312
Bratu, S., Tolaney, P., Karumudi, U., Quale, J., Mooty, M., Nichani, S., & Landman, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki175 · Cited by 307
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Freire, A. T., Melnyk, V., Kim, M. J., Datsenko, O., Dzyublik, O., Glumcher, F., Chuang, Y.-C., Maroko, R. T., Dukart, G., Cooper, C. A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.05.012 · Cited by 284
Rodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., & Quale, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.3018-3020.2005 · Cited by 246
Thomson, K. S., & Moland, E. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3548-3554.2001 · Cited by 245
Chastre, J., Wunderink, R., Prokocimer, P., Lee, M., Kaniga, K., & Friedland, I. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181691b99 · Cited by 237
Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00186-06 · Cited by 232
Ratjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
Chamot, E., Boffi El Amari, E., Rohner, P., & Van Delden, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2756-2764.2003 · Cited by 218
Anthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., & Li, L.-J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01053-06 · Cited by 205
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
Tenover, F. C., Kalsi, R. K., Williams, P. P., Carey, R. B., Stocker, S., Lonsway, D., Rasheed, J. K., Biddle, J. W., McGowan, J. E., & Hanna, B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1208.060291 · Cited by 199
Fosfomycin: an old, new friend?
Popovic, M., Steinort, D., Pillai, S., & Joukhadar, C. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0833-2 · Cited by 197
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4423-4424.2005 · Cited by 190
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Reinert, R. R., Low, D. E., Rossi, F., Zhang, X., Wattal, C., & Dowzicky, M. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm310 · Cited by 189
Bad Bugs, No Drugs: No ESCAPE Revisited
Peterson, L. R. (2009) · Clinical Infectious Diseases · doi:10.1086/605539 · Cited by 187
Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn311 · Cited by 186
Rossi, F. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl199 · Cited by 181
Payne, D. J., Cramp, R., Winstanley, D. J., & Knowles, D. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.767 · Cited by 171
Colistin susceptibility testing by Etest and disk diffusion methods
Galani, I., Kontopidou, F., Souli, M., Rekatsina, P.-D., Koratzanis, E., Deliolanis, J., & Giamarellou, H. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.011 · Cited by 169
Mushtaq, S., Ge, Y., & Livermore, D. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3086-3092.2004 · Cited by 164
Long-term Benefits of Inhaled Tobramycin in Adolescent Patients With Cystic Fibrosis
Moss, R. B. (2002) · CHEST Journal · doi:10.1378/chest.121.1.55 · Cited by 156
Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
Tam, V. H., Rogers, C. A., Chang, K., Weston, J. S., Caeiro, J., & Garey, K. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-10 · Cited by 155
Kallel, H., Hergafi, L., Bahloul, M., Hakim, A., Dammak, H., Chelly, H., Hamida, C. B., Chaari, A., Rekik, N., & Bouaziz, M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0675-2 · Cited by 154
Garau, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01852.x · Cited by 145
In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa
Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., & Hatano, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-06 · Cited by 140
Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin
Κοντοπούλου, Κ., Protonotariou, E., Vasilakos, K., Kriti, M., Koteli, A., Antoniadou, E., & Sofianou, D. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2010.03.021 · Cited by 138
Samra, Z., Ofir, O., Lishtzinsky, Y., Madar-Shapiro, L., & Bishara, J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.024 · Cited by 129
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Prospects for the next anti-Pseudomonas drug
Page, M. G. P., & Heim, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.006 · Cited by 125
Endimiani, A., Luzzaro, F., Perilli, M., Lombardi, G., Coli, A., Tamborini, A., Amicosante, G., & Toniolo, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380645 · Cited by 112
Saiman, L. M., Chen, Y., Gabriel, P. S., & Knirsch, C. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1105-1107.2002 · Cited by 108
Brown, R. B., Kruse, J. A., Counts, G. W., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.269 · Cited by 97
Pillar, C. M., Torres, M. K., Brown, N. P., Shah, D., & Sahm, D. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-08 · Cited by 79
Gavin, P. J., Suseno, M. T., Thomson, R. B., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S. M., Rotstein, C., Brossette, S. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-05 · Cited by 75
Dubois, V., Arpin, C., Melon, M., Melon, B., Andre, C., Frigo, C., & Quentin, C. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2072-2078.2001 · Cited by 73
Peterson, L. R. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01864.x · Cited by 62
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
Falagas, M. E., Karageorgopoulos, D. E., & Dimοpoulos, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048356 · Cited by 62
Segal‐Maurer, S., Mariano, N., Qavi, A., Urban, C. M., & Rahal, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/514754 · Cited by 60
Kaye, K. S., Kanafani, Z. A., Dodds, A. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00060-06 · Cited by 54
Self-citationIn Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem
Koga, T., Abe, T., Inoue, H., Takenouchi, T., Kitayama, A., Yoshida, T., Masuda, N., Sugihara, C., Kakuta, M., Nakagawa, M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3239-3250.2005 · Cited by 52
Korvick, J. A., Peacock, J. E., Muder, R. R., Wheeler, R. R., & Yu, V. L. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.620 · Cited by 52
Milne, K., & Gould, I. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp384 · Cited by 51
Lister, P., & Wolter, D. J. (2005) · Clinical Infectious Diseases · doi:10.1086/426190 · Cited by 47
Extended-spectrum β-lactamases: structure and kinetic mechanism
Page, M. G. P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01863.x · Cited by 45
Novel imidazole substituted 6-methylidene-penems as broad-spectrum β-lactamase inhibitors
Venkatesan, A. M., Agarwal, A. K., Abé, T., Ushirogochi, H., Yamamura, I., Kumagai, T., Petersen, P. J., Weiss, W. J., Lenoy, E., Yang, Y., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.08.039 · Cited by 45
Juanita Zamorano, R. (2004) · Revista chilena de infectología · doi:10.4067/s0716-10182004000300014 · Cited by 42
Bellais, S., Mimoz, O., Léotard, S., Jacolot, A., Petitjean, O., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.2032-2034.2002 · Cited by 35
Feldman, C. H., White, H. T., O’Grady, J., Flitcroft, A., Briggs, A., & Richards, G. A. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00344-7 · Cited by 31
Cited by
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and Management
Kaye, K. S., & Pogue, J. M. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1636 · Cited by 383
Cerceo, E., Deitelzweig, S. B., Sherman, B. M., & Amin, A. N. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0220 · Cited by 313
Hammoudi Halat, D., & Ayoub Moubareck, C. (2020) · Antibiotics · doi:10.3390/antibiotics9040186 · Cited by 287
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
Metadata
- Authors
- Kanj, S. S., & Kanafani, Z. A.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 86
- Issue
- 3
- Pages
- 250-259
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2135825675
- Cited by
- 269
- References
- 78
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.